The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Late Thursday, the US Food and Drug Administration revealed it is taking a ground-breaking step to advance public health by ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Human-Based Lab Models: The FDA will promote the use of lab-grown human “organoids” and organ-on-a-chip systems that mimic ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and autoimmunity.

Shares of Charles River Laboratories International, Inc. (CRL) traded over 3% lower on Friday morning after the U.S. Food and ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

The global antibody market is poised for remarkable expansion over the next decade, with market estimates predicting a significant rise in valuation from USD 266.83 billion in 2024 to an impressive ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

Biocon subsidiary, Biocon Biologics, on Thursday announced the approval of its antibody Jobevne by the U.S. Food and Drug ...